HOME >> BIOLOGY >> NEWS
Gold 'nanoplugs' wire up enzymes

UPTON, NY -- Scientists at Hebrew University, Israel, in collaboration with researchers at the U.S. Department of Energy's Brookhaven National Laboratory, have devised a way to use gold nanoparticles as tiny electrical wires to plug enzymes into electrodes. The gold "nanoplugs" help align the molecules for optimal binding and provide a conductive pathway for the flow of electrons. The research, described in the March 21, 2003, issue of Science, may yield more sensitive, inexpensive, noninvasive detectors for measuring biological molecules, including, potentially, agents of bioterrorism.

The idea behind the technology, says Brookhaven biologist Jim Hainfeld, who developed the gold nanoparticles and the means of attaching them to other molecules, is to measure the current as an indicator of the number of biological molecules involved in the reaction.

One potential application, developed by the Hebrew University collaborators, is to use sensors made from the enzyme-electrode system to measure blood glucose in diabetic patients. In the Science paper, the authors describe how they used gold nanoparticles to attach a glucose-oxidizing enzyme to an electrode, and then used this bioelectrocatalytic system to measure glucose levels.

"The gold nanoparticle --1.4 nanometers, or billionths of a meter, in diameter -- plays two very important roles," says Hainfeld. "First, it specifically orients the binding of the enzyme to the electrode so it's a very ordered attachment, not random. Second, since gold is a conductor, it provides an electrical path for the flow of electrons."

When the enzyme oxidizes glucose, electrons flow through the gold nanoparticle into the electrode: The higher the current, the higher the level of glucose.

The experimental results indicate that current flowed seven times faster with the "plugged-in" enzyme system than with the normal enzyme using oxygen as an electron acceptor. Previous attempts to wire the enzyme
'"/>

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
20-Mar-2003


Page: 1 2

Related biology news :

1. Two enzymes key to calorie-burning, Brown research shows
2. Study finds first evidence COX-2 enzymes can regulate DNA damage
3. New research at UNC shows ribosomes do not function as conventional enzymes
4. Findings redefine mechanism of action of RNA helicase enzymes
5. Carnegie Mellon U. develops microgel to recover enzymes for manufacturing, research assays
6. Methuselah enzymes: SEN and the art of molecule maintenance
7. Computer method identifies potentially active enzymes
8. Emory scientists use enzymes to enhance regeneration of damaged peripheral nerves in mice
9. Study finds direction of enzymes affects DNA repair
10. Boston chemist wins national award for research with enzymes, antibiotics
11. Smart polymers provide light-activated switch to turn enzymes on and off

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2019)... ... 02, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human ... approved clinical trial for stem cell treatment of knee osteoarthritis . The successful enrollment ... a subsidiary of VetStem Biopharma. , PSC CEO, Michael Dale, stated, “We are proud ...
(Date:9/30/2019)... ... September 30, 2019 , ... RoosterBio ... stem/stromal cell (hMSC) biomanufacturing systems, today announced it has received patent approval ... formats (patent number AU 2015259373). This new patent adds intellectual property (IP) ...
(Date:9/25/2019)... ... September 25, 2019 , ... Deep Science Ventures (DSV), a ... world’s largest independent funder of cancer research. , Deep Science Ventures was founded to ... view of the opportunity from the start, both at the industry and biological level. ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... (PRWEB) , ... October 02, 2019 , ... ... new life sciences leadership firm that is enabling clinical program outsourcing success by ... Founded by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients ...
(Date:10/3/2019)... ... , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials New ... M.D., Ph.D., discussed important design factors that currently limit the success of early stage ... of clinical trials, in his talk Dr. Sherley focused on the highly ...
(Date:9/24/2019)... and WALTHAM, Mass. (PRWEB) , ... ... ... the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of ...
(Date:9/22/2019)... BEAVERTON, Ore. (PRWEB) , ... September 20, 2019 ... ... the commercial launch of Brain-Derived Neurotrophic Factor (BDNF) testing in serum . ... peripheral nervous systems. BDNF stimulates the growth and differentiation of new neurons in ...
Breaking Biology Technology:
Cached News: